Rocket Pharmaceuticals, Inc. (RCKT)

RCKT displays a bearish profile: the stock trades beneath most medium- and long-term moving averages while short-term averages sit near the current price, and ADX indicates a modestly entrenched trend. Momentum readings are mixed — oscillators show oversold conditions but MACD and momentum are weak — and on-balance volume is deeply negative, signaling distribution. Volatility is elevated for the price level, and classic pivot sits essentially at the market price. Technical takeaway: Strong Sell — price below key long-term averages with weak momentum and declining volume.